Kiniksa Pharmaceuticals LtdNASDAQ:KNSA
- LAST PRICE21.4800
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots20.0100/ 1
- Ask / Lots20.5200/ 1
- Open / Previous Close--- / 21.4800
- Day Range---
- 52 Week Range
- Volume25
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | KNSA |
|---|---|---|
| 09:32 ET | 4755 | 22.26 |
| 09:33 ET | 3830 | 22.26 |
| 09:35 ET | 1210 | 22.02 |
| 09:37 ET | 300 | 22.08 |
| 09:39 ET | 500 | 22.19 |
| 09:44 ET | 125 | 22.2246 |
| 09:46 ET | 10424 | 22.07 |
| 09:48 ET | 570 | 22.175 |
| 09:51 ET | 300 | 22.165 |
| 09:53 ET | 400 | 22.04 |
| 09:55 ET | 2700 | 21.93 |
| 09:57 ET | 616 | 21.918 |
| 10:00 ET | 595 | 21.85 |
| 10:02 ET | 8055 | 21.82 |
| 10:04 ET | 2212 | 21.885 |
| 10:08 ET | 147 | 21.865 |
| 10:09 ET | 1070 | 21.87 |
| 10:11 ET | 100 | 21.938 |
| 10:13 ET | 200 | 21.94 |
| 10:15 ET | 300 | 21.93 |
| 10:20 ET | 300 | 21.955 |
| 10:22 ET | 200 | 22 |
| 10:24 ET | 200 | 22.025 |
| 10:26 ET | 500 | 22.03 |
| 10:27 ET | 2400 | 21.94 |
| 10:29 ET | 190 | 21.941 |
| 10:31 ET | 700 | 21.86 |
| 10:33 ET | 11781 | 21.7 |
| 10:36 ET | 300 | 21.66 |
| 10:38 ET | 989 | 21.785 |
| 10:40 ET | 101 | 21.785 |
| 10:42 ET | 1300 | 21.87 |
| 10:44 ET | 1800 | 21.93 |
| 10:45 ET | 4214 | 21.98 |
| 10:47 ET | 300 | 22.015 |
| 10:49 ET | 531 | 22.06 |
| 10:54 ET | 314 | 22.075 |
| 10:56 ET | 150 | 22.1026 |
| 11:02 ET | 100 | 22.13 |
| 11:03 ET | 300 | 22.16 |
| 11:05 ET | 3933 | 21.955 |
| 11:07 ET | 100 | 21.955 |
| 11:09 ET | 100 | 21.955 |
| 11:14 ET | 1300 | 22.0357 |
| 11:16 ET | 100 | 22.01 |
| 11:18 ET | 100 | 22.05 |
| 11:21 ET | 1500 | 21.94 |
| 11:27 ET | 200 | 21.83 |
| 11:32 ET | 100 | 21.8 |
| 11:34 ET | 200 | 21.79 |
| 11:36 ET | 100 | 21.84 |
| 11:38 ET | 200 | 21.79 |
| 11:39 ET | 100 | 21.74 |
| 11:41 ET | 300 | 21.705 |
| 11:43 ET | 8951 | 21.7 |
| 11:45 ET | 716 | 21.74 |
| 11:48 ET | 2400 | 21.69 |
| 11:50 ET | 181 | 21.715 |
| 11:52 ET | 200 | 21.69 |
| 11:54 ET | 1863 | 21.61 |
| 11:56 ET | 5648 | 21.655 |
| 12:03 ET | 200 | 21.6395 |
| 12:06 ET | 200 | 21.63 |
| 12:08 ET | 6966 | 21.68 |
| 12:14 ET | 200 | 21.785 |
| 12:15 ET | 300 | 21.8 |
| 12:17 ET | 200 | 21.81 |
| 12:19 ET | 1100 | 21.95 |
| 12:21 ET | 175 | 21.99 |
| 12:24 ET | 300 | 22.03 |
| 12:26 ET | 261 | 22.07 |
| 12:30 ET | 200 | 22.08 |
| 12:32 ET | 407 | 22.09 |
| 12:33 ET | 100 | 22.095 |
| 12:37 ET | 300 | 22.13 |
| 12:39 ET | 451 | 22.15 |
| 12:42 ET | 100 | 22.145 |
| 12:46 ET | 874 | 22.17 |
| 12:48 ET | 100 | 22.2 |
| 12:51 ET | 200 | 22.24 |
| 12:55 ET | 1000 | 22.2249 |
| 12:57 ET | 2300 | 22.16 |
| 01:02 ET | 200 | 22.16 |
| 01:04 ET | 100 | 22.155 |
| 01:08 ET | 100 | 22.155 |
| 01:11 ET | 100 | 22.155 |
| 01:13 ET | 1008 | 22.2 |
| 01:15 ET | 590 | 22.21 |
| 01:18 ET | 100 | 22.205 |
| 01:20 ET | 154 | 22.2271 |
| 01:22 ET | 100 | 22.22 |
| 01:24 ET | 1029 | 22.16 |
| 01:27 ET | 200 | 22.16 |
| 01:31 ET | 300 | 22.14 |
| 01:33 ET | 100 | 22.13 |
| 01:36 ET | 100 | 22.1204 |
| 01:45 ET | 200 | 22.13 |
| 01:47 ET | 1388 | 22.12 |
| 01:49 ET | 200 | 22.09 |
| 01:51 ET | 900 | 22.08 |
| 01:58 ET | 300 | 22.01 |
| 02:00 ET | 200 | 21.97 |
| 02:05 ET | 300 | 21.87 |
| 02:07 ET | 200 | 21.87 |
| 02:09 ET | 100 | 21.88 |
| 02:12 ET | 391 | 21.87 |
| 02:14 ET | 100 | 21.87 |
| 02:16 ET | 900 | 21.84 |
| 02:18 ET | 510 | 21.82 |
| 02:20 ET | 100 | 21.82 |
| 02:21 ET | 700 | 21.81 |
| 02:23 ET | 200 | 21.79 |
| 02:25 ET | 8237 | 21.81 |
| 02:27 ET | 596 | 21.75 |
| 02:30 ET | 2837 | 21.76 |
| 02:32 ET | 949 | 21.79 |
| 02:34 ET | 5246 | 21.875 |
| 02:36 ET | 8197 | 21.82 |
| 02:38 ET | 300 | 21.85 |
| 02:39 ET | 200 | 21.83 |
| 02:45 ET | 1400 | 21.75 |
| 02:48 ET | 100 | 21.8 |
| 02:50 ET | 500 | 21.8 |
| 02:52 ET | 400 | 21.74 |
| 02:54 ET | 422 | 21.76 |
| 02:56 ET | 4069 | 21.73 |
| 02:57 ET | 400 | 21.735 |
| 02:59 ET | 300 | 21.7 |
| 03:01 ET | 3953 | 21.66 |
| 03:03 ET | 2425 | 21.665 |
| 03:06 ET | 1322 | 21.675 |
| 03:08 ET | 200 | 21.69 |
| 03:10 ET | 200 | 21.675 |
| 03:12 ET | 700 | 21.71 |
| 03:15 ET | 300 | 21.69 |
| 03:17 ET | 100 | 21.685 |
| 03:19 ET | 4302 | 21.55 |
| 03:21 ET | 300 | 21.55 |
| 03:24 ET | 1700 | 21.53 |
| 03:26 ET | 4451 | 21.57 |
| 03:28 ET | 100 | 21.56 |
| 03:32 ET | 2500 | 21.535 |
| 03:33 ET | 2143 | 21.59 |
| 03:35 ET | 500 | 21.6343 |
| 03:37 ET | 715 | 21.561 |
| 03:42 ET | 2566 | 21.59 |
| 03:44 ET | 4635 | 21.58 |
| 03:46 ET | 367 | 21.575 |
| 03:48 ET | 951 | 21.57 |
| 03:50 ET | 500 | 21.551 |
| 03:51 ET | 5370 | 21.55 |
| 03:53 ET | 8852 | 21.521 |
| 03:55 ET | 10844 | 21.48 |
| 03:57 ET | 4012 | 21.45 |
| 04:00 ET | 82342 | 21.48 |
Oct 30, 2024
DJ Kiniksa Pharmaceuticals Is Maintained at Outperform by Evercore ISI Group, from 11:07AM ET on Wednesday Oct 30, 2024 by Dow Jones
11:07AM ET on Wednesday Oct 30, 2024 by Dow Jones
Oct 29, 2024
DJ Kiniksa Pharmaceuticals Down Over 12%, on Pace for Largest Percent Decrease Since August 2021 -- Data Talk, from 11:09AM ET on Tuesday Oct 29, 2024 by Dow Jones
11:09AM ET on Tuesday Oct 29, 2024 by Dow JonesKiniksa Pharmaceuticals Reports Third Quarter 2024 Financial Results and Recent Portfolio Execution, from 7:30AM ET on Tuesday Oct 29, 2024 by Dow Jones
7:30AM ET on Tuesday Oct 29, 2024 by Dow Jones*DJ Kiniksa Pharmaceuticals 3Q Loss/Shr 18c >KNSA, from 7:30AM ET on Tuesday Oct 29, 2024 by Dow Jones
7:30AM ET on Tuesday Oct 29, 2024 by Dow Jones
Oct 28, 2024
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Kiniksa Pharmaceuticals Ltd | 1.6B | -135.6x | --- |
Dynavax Technologies Corp | 1.5B | 116.6x | --- |
BioCryst Pharmaceuticals Inc | 1.5B | -12.1x | --- |
CareDx Inc | 1.2B | -7.7x | --- |
Maravai LifeSciences Holdings Inc | 2.0B | -7.8x | --- |
Xencor Inc | 1.5B | -7.4x | --- |
Company Information
Kiniksa Pharmaceuticals, Ltd. is a biopharmaceutical company. The Company is focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. Its portfolio of immune-modulating assets, ARCALYST (rilonacept), KPL-404 and mavrilimumab, are based on strong biologic rationale or validated mechanisms, target a spectrum of underserved cardiovascular and autoimmune conditions, and offer the potential for differentiation. The Company’s ARCALYST is interleukin-1alpha (IL-1α), and interleukin-1beta (IL-1β), cytokine trap for the treatment of recurrent pericarditis and reduction in risk of recurrence in adults and children. Its KPL-404 is an investigational monoclonal antibody inhibitor of CD40-CD154 interaction. The Company’s Mavrilimumab is an investigational monoclonal antibody inhibitor targeting granulocyte-macrophage colony stimulating factor receptor alpha (GM-CSFRα).
Contact Information
- Headquarters
- Clarendon House, 2 Church StreetHAMILTON, Bermuda HM11
- Phone
- ---
- Fax
- ---
Executives
- Chairman of the Board, Chief Executive Officer
- Sanjiv Patel
- Chief Financial Officer, Senior Vice President
- Mark Ragosa
- Chief Operating Officer, Senior Vice President
- Eben Tessari
- Senior Vice President, Chief Commercial Officer
- Ross Moat
- Senior Vice President, Chief Medical Officer
- John Paolini
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.6B |
|---|---|
Revenue (TTM) | $384.1M |
Shares Outstanding | 72.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.29 |
EPS | $-0.16 |
Book Value | $6.23 |
P/E Ratio | -135.6x |
Price/Sales (TTM) | 4.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -6.83% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
